Patients with ovarian cancer (OC) may develop anti‐Yo‐associated paraneoplastic cerebellar degeneration (PCD)—a cerebellar ataxia associated with tumor‐induced autoimmunity against CDR2 and CDR2L proteins. Here, CDR2L is linked to neoplasm.